Purple Biotech (PPBT) Total Current Liabilities (2014 - 2026)
Purple Biotech (PPBT) reported Total Current Liabilities of $4.6 million for Q1 2026, down 40.76% on a QoQ basis from $7.8 million in Q4 2025.
Purple Biotech (PPBT) has 11 years of Total Current Liabilities data on file, last reported at $4.6 million in Q1 2026.
- Quarterly Total Current Liabilities changed N/A year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (changed N/A YoY) and the FY2025 annual result came in at $7.8 million, up 94.46% from the prior year.
- Total Current Liabilities retreated to $4.6 million in Q1 2026 per PPBT's latest filing, from $7.8 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $9.7 million in Q4 2023 and bottomed at $4.0 million in Q4 2024.
- The 5-year median for Total Current Liabilities is $7.1 million (2022), against an average of $6.6 million.
- The widest annual swing landed in 2024, when Total Current Liabilities sank 58.9%; it then surged 94.46% in 2025.
- Tracing PPBT's Total Current Liabilities over 5 years: stood at $7.1 million in 2022, then surged by 37.45% to $9.7 million in 2023, then sank by 58.9% to $4.0 million in 2024, then surged by 94.46% to $7.8 million in 2025, then sank by 40.76% to $4.6 million in 2026.
- Per Business Quant, the three latest PPBT Total Current Liabilities figures stand at $4.6 million (Q1 2026), $7.8 million (Q4 2025), and $4.0 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.11 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.35 Bn |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - | 4.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.59 Mn |
| Dec 31, 2025 | 7.75 Mn |
| Sep 30, 2025 | 6.06 Mn |
| Jun 30, 2025 | 2.19 Mn |
| Mar 31, 2025 | 2.76 Mn |
| Dec 31, 2024 | 3.99 Mn |
| Sep 30, 2024 | 5.46 Mn |
| Jun 30, 2024 | 6.47 Mn |
| Mar 31, 2024 | 8.51 Mn |
| Dec 31, 2023 | 9.70 Mn |
| Sep 30, 2023 | 6.22 Mn |
| Jun 30, 2023 | 4.88 Mn |
| Mar 31, 2023 | 5.62 Mn |
| Dec 31, 2022 | 7.06 Mn |
| Sep 30, 2022 | 5.93 Mn |
| Jun 30, 2022 | 5.39 Mn |
| Mar 31, 2022 | 7.19 Mn |
| Dec 31, 2021 | 4.25 Mn |
| Sep 30, 2021 | 3.43 Mn |
| Jun 30, 2021 | 3.50 Mn |
| Mar 31, 2021 | 5.97 Mn |
| Dec 31, 2020 | 3.10 Mn |
| Jun 30, 2020 | 29.38 Mn |
| Dec 31, 2019 | 3.55 Mn |
| Jun 30, 2019 | 5.37 Mn |
| Dec 31, 2018 | 3.31 Mn |
| Jun 30, 2018 | 7.24 Mn |
| Dec 31, 2017 | 3.97 Mn |
| Jun 30, 2017 | 1.18 Mn |
| Dec 31, 2016 | 1.27 Mn |
| Jun 30, 2016 | 1.83 Mn |
| Dec 31, 2015 | 1.20 Mn |
| Sep 30, 2015 | 1.32 Mn |
| Dec 31, 2014 | 986,000.00 |
| Sep 30, 2014 | 1.41 Mn |